Status:
ENROLLING_BY_INVITATION
Healing After Augmentation of Alveolar Ridge Using Collagen Membrane
Lead Sponsor:
University of Belgrade
Conditions:
Bone Healing
Augmentation
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
One of the prerequisites for successful prosthetic implant therapy of patients is achieving the initial stability of the embedded implant, which largely depends on the width alveolar ridge, at the pla...
Detailed Description
The physiological process of bone tissue resorption after tooth extraction results in significant by changing the initial dimension of the alveolar ridge, due to horizontal and vertical resorption of ...
Eligibility Criteria
Inclusion
- ASA I classification of health status,
- Non-smokers or consumption of up to 10 cigarettes per day,
- No signs of gingival inflammation,
- Late installation of implants,
- The possibility of achieving the primary stability of the implant,
- The dimension of the residual alveolar ridge for implant placement ≥5 mm wide, height ≥12 mm,
- Diagnosed fenestration, dehiscence of buccal bony lamella ≤3 mm in size and/or thickness of buccal bone lamella ≤1.5 mm,
- Plaque index (PI) and gingival bleeding on provocation (KNP) \<15% and probing depth (DS) \<3 mm,
- Preserved cemento-enamel border (CGG) without the presence of non-carious cervical lesions (NCL), or the presence of a defect in the root area up to 1mm deep with preserved CGG,
- Preserved interjaw relationships.
Exclusion
- Systemic acute administration of drugs up to 7 days before surgical intervention,
- Systemic chronic administration of steroids or non-steroidal anti-inflammatory drugs,
- History of oral surgical interventions in the last 4 months,
- Poor oral hygiene,
- Demonstrated hypersensitivity to collagen,
- Pregnancy and breastfeeding,
- Patient withdrawal from the research protocol in any evaluation period,
- Patients who underwent standard augmentation of bone tissue with a substitute for bone and membrane, after implant installation,
- Participation in clinical research in the last 6 months
Key Trial Info
Start Date :
March 7 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2029
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06885983
Start Date
March 7 2025
End Date
November 1 2029
Last Update
March 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
School of Sental Medicine
Belgrade, Serbia, 011